Supporting a diverse portfolio
CARB-X supports projects through the early development phases so that they will attract additional private or public support for further clinical development. The portfolio is constantly evolving, with new projects, advancements into clinical development, and achievement of milestones on the path to clinical trials. CARB-X supports therapeutics and vaccines projects through the early stages of product development and Phase 1, and supports diagnostics from the Feasibility stage through Development and external testing of an alpha prototype. The goal is to support these potentially life-saving projects so they can attract private or public investment for further development.